SCHEMBL2000889

SCHEMBL2000889

O=C(CC(=O)Nc1ccc(Oc2ccccc2)cc1)Nc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNF4 P78317 1/20 0.77
ALDH1A1 P00352 3/20 0.67
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
RECQL P46063 1/20 0.67
HPGD P15428 2/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
PGR P06401 1/20 0.66
HDAC1 Q13547 3/20 0.65
HDAC3 O15379 2/20 0.65
HDAC4 P56524 2/20 0.65
HDAC7 Q8WUI4 2/20 0.65
HDAC2 Q92769 2/20 0.65
HDAC10 Q969S8 2/20 0.65
HDAC11 Q96DB2 2/20 0.65
HDAC8 Q9BY41 2/20 0.65
HDAC6 Q9UBN7 2/20 0.65
HDAC9 Q9UKV0 2/20 0.65
HDAC5 Q9UQL6 2/20 0.65
LTA4H P09960 4/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20942365 0.92 RNF4 (0.71) RNF4ALDH1A1MEN1KMT2ARECQL
SCHEMBL20941574 0.92 MEN1 (0.68) RNF4ALDH1A1MEN1KMT2ARECQL
SCHEMBL20941569 0.92 RNF4 (0.67) RNF4ALDH1A1MEN1KMT2ARECQL
SCHEMBL20942366 0.92 RNF4 (0.67) RNF4ALDH1A1MEN1KMT2ARECQL
SCHEMBL23323205 0.92 POLB (0.68) RNF4ALDH1A1MEN1KMT2ARECQL
SCHEMBL20942364 0.87 KMT2A (0.68) RNF4ALDH1A1MEN1KMT2ARECQL
SCHEMBL20941788 0.87 FNTA (0.67) RNF4ALDH1A1MEN1KMT2ARECQL
SCHEMBL20941792 0.87 RNF4 (0.71) RNF4ALDH1A1MEN1KMT2ARECQL
SCHEMBL2173035 0.87 MTNR1A (0.73) RNF4ALDH1A1MEN1KMT2ARECQL
SCHEMBL3382618 0.87 RNF4 (1.00) RNF4ALDH1A1MEN1KMT2ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7964625-B2 Antibiotics comprising bis(1-aryl-5-tetrazoly1)methane derivatives NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2011-06-21 US disclosed
EP-1937257-B1 NOVEL ANTIBIOTICS COMPRISING BIS(1-ARYL-5-TETRAZ0LYL)METHANE DERIVATIVES TNO (NL) 2010-12-08 EP disclosed
US-20080280964-A1 Novel Antibiotics Comprising Bis(1-Aryl-5-Tetrazolyl)Methane Derivatives NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280964-A1 Novel Antibiotics Comprising Bis(1-Aryl-5-Tetrazolyl)Methane Derivatives LAS1L, AAAS, RPS5 RNF4 693/4885ALDH1A1 3743/4885MEN1 1009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.